Advertisement

Inpharma Weekly

, Volume 1304, Issue 1, pp 9–9 | Cite as

Pegylated liposomal doxorubicin promising in ovarian cancer

Clinical study
  • 5 Downloads

Keywords

Ovarian Cancer Ovarian Carcinoma Topotecan Objective Response Rate Liposomal Doxorubicin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2001

Personalised recommendations